BRIEF-Lyell Immunopharma Q4 Net Income USD -191.935 Million

Reuters
11 Mar

Mar 11 (Reuters) - Lyell Immunopharma Q4 operating expenses USD 201.158 million.

  • Q4 operating income USD -201.147 million
  • Q4 revenue USD 11 thousand

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

no data

No relevant data is available

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."